Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients

Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients

Ursodeoxycholic acid (UDCA) was demonstrated to reduce susceptibility to SARS-CoV-2 infection in vitro and improve infection course in chronic liver diseases. However, real-life evidence is lacking. We analyzed the impact of UDCA on COVID-19 outcomes in patients hospitalized in a tertiary center. Be...

Full description

Bibliographic Details
Main Authors: Francesca Colapietro, Giovanni Angelotti, Chiara Masetti, Dana Shiffer, Nicola Pugliese, Stella De Nicola, Francesco Carella, Antonio Desai, Monica Ormas, Marta Calatroni, Paolo Omodei, Michele Ciccarelli, Stefano Aliberti, Francesco Reggiani, Michele Bartoletti, Maurizio Cecconi, Ana Lleo, Alessio Aghemo, Antonio Voza
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Viruses
Subjects:
UDCA
COVID-19
ACE2
Online Access:https://www.mdpi.com/1999-4915/15/8/1738

Internet

https://www.mdpi.com/1999-4915/15/8/1738

Similar Items